Chet Bohac

Chet Bohac has a strong background in the medical field, with extensive experience in various leadership roles. Chet is currently the Executive Medical Director at Xencor. This position, which they started in March 2023, emphasizes their expertise and ability to lead medical teams. Prior to this role, Chet served as an Executive Consultant in 2022, where they provided valuable insights and advice to organizations. From 2019 to 2022, they worked at MacroGenics, Inc. as the Executive Director of Clinical Research and Clinical Development, showcasing their capabilities in directing clinical research efforts. Before that, they held the position of Senior Medical Director at Immune Design from 2016 to 2019, where they demonstrated their expertise in medical decision-making. Chet's experience also includes serving as a Medical Director at Amgen from 2010 to 2016, where they played a key role in medical management. Chet began their professional career as an Assistant Professor in Oncology at Rush Medical College of Rush University Medical Center from June 2007 to May 2010, highlighting their passion for teaching and academic contributions.

Chet Bohac completed their Master of Science in Epidemiology at Boston University School of Public Health from 2003 to 2007.